uniQure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade uniQure 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About QURE
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.
CEOMatthew C. Kapusta
CEOMatthew C. Kapusta
Employees209
Employees209
HeadquartersAmsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded2012
Founded2012
Employees209
Employees209
QURE Key Statistics
Market cap1.72B
Market cap1.72B
Price-Earnings ratio-6.37
Price-Earnings ratio-6.37
Dividend yield—
Dividend yield—
Average volume2.36M
Average volume2.36M
High today$28.28
High today$28.28
Low today$26.80
Low today$26.80
Open price$27.80
Open price$27.80
Volume1.92M
Volume1.92M
52 Week high$71.50
52 Week high$71.50
52 Week low$5.86
52 Week low$5.86
Stock Snapshot
The current uniQure(QURE) stock price is $27.96, with a market capitalization of 1.72B. The stock trades at a price-to-earnings (P/E) ratio of -6.37.
As of 2025-11-26, uniQure(QURE) stock has fluctuated between $26.80 and $28.28. The current price stands at $27.96, placing the stock +4.3% above today's low and -1.1% off the high.
The uniQure(QURE)'s current trading volume is 1.92M, compared to an average daily volume of 2.36M.
In the last year, uniQure(QURE) shares hit a 52-week high of $71.50 and a 52-week low of $5.86.
In the last year, uniQure(QURE) shares hit a 52-week high of $71.50 and a 52-week low of $5.86.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
23.1%
Sell
0%
People also own
Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.